Elisabeth A. Bone
Publications by Year
Research Areas
Peptidase Inhibition and Analysis, Histone Deacetylase Inhibitors Research, Protease and Inhibitor Mechanisms, Protein Degradation and Inhibitors, Signaling Pathways in Disease
Most-Cited Works
- → Matrix metalloproteinases degrade myelin basic protein(1995)293 cited
- → Preclinical and Clinical Studies of MMP Inhibitors in Cancer(1999)221 cited
- → Rapid accumulation of inositol phosphates in isolated rat superior cervical sympathetic ganglia exposed to V1-vasopressin and muscarinic cholinergic stimuli(1984)221 cited
- → Effect of Matrix Metalloproteinase Inhibitor Batimastat on Breast Cancer Regrowth and Metastasis in Athymic Mice(1995)193 cited
- Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94).(1996)
- → A vasopressin-like peptide in the mammalian sympathetic nervous system(1984)143 cited
- → CHR-2797: An Antiproliferative Aminopeptidase Inhibitor that Leads to Amino Acid Deprivation in Human Leukemic Cells(2008)117 cited
- The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice.(1996)
- Batimastat, a synthetic inhibitor of matrix metalloproteinases, potentiates the antitumor activity of cisplatin in ovarian carcinoma xenografts.(1998)
- → Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor(2010)83 cited